Klaus Schollmeier

Director/Miembro de la Junta en HEIDELBERG PHARMA AG .

69 años

Health Technology

Consumer Services

Finance

Perfil

Currently, Klaus Schollmeier is Chairman at Anergis SA, Eternygen GmbH, and TACALYX GmbH; Chairman-Supervisory Board at Inthera Bioscience AG; Member-Supervisory Board at Heidelberg Pharma AG, Minaris Regenerative Medicine GmbH, Novaliq GmbH; and Independent Member-Supervisory Board at CureVac NV.
Formerly, the roles include Chief Executive Officer at SuppreMol GmbH (2013–2015), Chairman at Santhera Pharmaceuticals Holding AG (2011–2012), Chairman at PCOVERY ApS, Managing Director at ING BHF-Bank AG, Senior Director-Biotechnology at BASF Bioresearch Corp.
(1989–1993), Director at Graffinity Pharmaceuticals AG, Principal at Knoll AG and Abbott GmbH (Germany), Research Associate Professor-Medical School at Boston University, General Manager at BASF Pharma (1996–1998), and Member-Supervisory Board at Modra Pharmaceuticals BV.
Education includes a doctorate from Heinrich-Heine-Universität Düsseldorf conferred in 1991.

Cargos activos de Klaus Schollmeier

Empresas	Cargo	Inicio
CUREVAC	Director/Miembro de la Junta	22/06/2022
HEIDELBERG PHARMA AG	Director/Miembro de la Junta	15/05/2025
Minaris Regenerative Medicine GmbH Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology Develops cell-based and gene therapy products	Director/Miembro de la Junta	-
Eternygen GmbH Eternygen GmbH Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs	Presidente	-
TACALYX GmbH TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors	Presidente	05/11/2020
Inthera Bioscience AG Inthera Bioscience AG BiotechnologyHealth Technology Develops, manufactures small bio molecule therapies for solid tumors	Presidente	-
Anergis SA Anergis SA Pharmaceuticals: GenericHealth Technology Provides allergy vaccines	Presidente	-
Novaliq GmbH Novaliq GmbH Medical SpecialtiesHealth Technology Develops and markets drug delivery systems	Director/Miembro de la Junta	-

Todos los cargos activos de Klaus Schollmeier

Antiguos cargos conocidos de Klaus Schollmeier.

Empresas	Cargo	Fin
ING BHF-Bank AG ING BHF-Bank AG Major BanksFinance Provides banking services	Corporate Officer/Principal	06/12/2018
░░░░░░░░░ ░░░░	░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░░	-
░░░░ ░░░░░░	░░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Ver el detalle de la experiencia de Klaus Schollmeier.

Formación de Klaus Schollmeier.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Klaus Schollmeier.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	20
Abbott GmbH (Germany) Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical, diagnostic, nutritional, and hospital products	Health Technology
Knoll AG Knoll AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ING BHF-Bank AG ING BHF-Bank AG Major BanksFinance Provides banking services	Finance
Graffinity Pharmaceuticals AG Graffinity Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Specializes in chemical genomics pharmaceutical products	Health Technology
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases	Health Technology
Heidelberg Pharma AG Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies	Health Technology
Heinrich-Heine-Universität Düsseldorf Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BASF Bioresearch Corp.
SuppreMol GmbH SuppreMol GmbH Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases	Health Technology
Anergis SA Anergis SA Pharmaceuticals: GenericHealth Technology Provides allergy vaccines	Health Technology
BASF Pharma
Pcovery ApS Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections	Health Technology
Eternygen GmbH Eternygen GmbH Pharmaceuticals: MajorHealth Technology Engages in the research and development of drugs	Health Technology
Novaliq GmbH Novaliq GmbH Medical SpecialtiesHealth Technology Develops and markets drug delivery systems	Health Technology
Minaris Regenerative Medicine GmbH Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology Develops cell-based and gene therapy products	Health Technology
Inthera Bioscience AG Inthera Bioscience AG BiotechnologyHealth Technology Develops, manufactures small bio molecule therapies for solid tumors	Health Technology
Modra Pharmaceuticals BV Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Designs and develops oral formulations of commonly used anti-cancer drugs	Health Technology
TACALYX GmbH TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors	Commercial Services
CureVac NV CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies	Health Technology